FDA Safety and Innovation Act secures supply chainPresident Obama recently signed the Food and Drug Administration Safety and Innovation Act, which is a piece of legislation that will increase the safety and security of the drug supply chain in the United States.

The newly signed legislation will also level the playing field in order to hold all drug manufacturers to the FDA's inspection standards and enhance the quality of pharmaceutical products while providing affordable generic drugs.

Global pharma company Mylan applauded the new law, saying it fits with Mylan's mission to set higher healthcare standards while providing 7 billion people with safe drugs.

"Mylan has long been a passionate leader and advocate for many of the key provisions included in this important piece of legislation that will help enhance our nation's drug supply chain, and we applaud the extraordinary efforts of the many in Congress who helped craft and pass this vital law in a bipartisan fashion," said Mylan CEO Heather Bresch.

Pharmaceutical supply chains are also combating counterfeiting, which undermines the safety of the worldwide pharma supply chain and has been increasingly problematic of late, according to recent report from GBI Research.
Share To:

Strategic Sourceror

Post A Comment:

0 comments so far,add yours